NATZOLD 5MG INFUSION

Natzold 5 mg Infusion is a source of the active ingredient Zoledronic Acid. It is part of the class of substances known as bisphosphonates. It’s used to lower the amount of calcium in patients’ blood when it is excessive because of tumours. Tumors can speed up regular bone changes where calcium release from bone increases. This is referred to as tumor-induced high calcium (TIH). It can also be utilized to avoid bone-related complications in adults with bone metastases and multiple myeloma caused by the solid tumour (spread by cancer cells from their original site onto the bone) as well as the standard treatment for cancer.

Natzold 5mg Infusion is recommended to treat or prevent osteoporosis (a condition where bones weaken and thin and easily break) for women who have gone through menopausal changes. It can also be utilized to prevent osteoporosis in males. It’s used to treat Paget’s disease of bones (a condition in which bones are weak and soft and susceptible to deformation and pain or fracture). Other applications include treating or preventing osteoporosis for women and men taking glucocorticoids (a corticosteroid medicine that can lead to osteoporosis).

Don’t take this medicine if you’re allergic to zoledronic acids or another bisphosphonate, as well as other components of this medication, or in the case of pregnancy or nursing. Before beginning treatment, notify your doctor whether you suffer from liver or kidney problems or bone conditions and swelling, pain or the sensation of numbness. This medication is not recommended for use by adolescents and youngsters under the age of 18 years old. Natzold 5mg Infusion does not function as chemotherapy for cancer and cannot slow or stop the progression of cancer. It can however be used to treat bone disorders for cancer patients.